Sign In to Follow Application
View All Documents & Correspondence

Novel Salt Forms Of A 4 H Pyran 4 One Structured Cyp11 A1 Inhibitor

Abstract: The present invention relates to novel salts, particularly crystalline salts, of 2-(isoindolin-2-ylmethyl)-5-((1-(methylsulfonyl)piperidin-4-yl)methoxy)-4H-pyran-4-one (I) which are particularly suitable for use in the manufacture of pharmaceutical 5 compositions. Furthermore, the invention relates to pharmaceutical compositions comprising such novel salts. Compound (I) is a selective inhibitor of CYP11A1 enzyme and is useful in the treatment of hormonally regulated cancers, such as prostate cancer and breast cancer.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
30 August 2023
Publication Number
49/2023
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

ORION CORPORATION
Orionintie 1 FI-02200 Espoo

Inventors

1. KARJALAINEN, Oskari
c/o FERMION OY Koivu-Mankkaan tie 6 FI-02200 Espoo
2. MÄKELÄ, Mikko
c/o ORION CORPORATION P.O.Box 65 FI-02101 Espoo
3. POP, Mihaela
Le Tourmalet 14 1060NX AMSTERDAM
4. RUMMAKKO, Petteri
c/o ORION CORPORATION P.O.Box 65 FI-02101 Espoo
5. SHEVCHENKO, Anna
Agern Allé 3 2970 HORSHOLM
6. SINERVO, Kai
c/o ORION CORPORATION P.O.Box 65 FI-02101 Espoo
7. TIAINEN, Eija
Ruutikatu 3 A 17 FI-02650 ESPOO

Specification

Documents

Application Documents

# Name Date
1 202317058209-STATEMENT OF UNDERTAKING (FORM 3) [30-08-2023(online)].pdf 2023-08-30
2 202317058209-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [30-08-2023(online)].pdf 2023-08-30
3 202317058209-FORM 1 [30-08-2023(online)].pdf 2023-08-30
4 202317058209-DRAWINGS [30-08-2023(online)].pdf 2023-08-30
5 202317058209-DECLARATION OF INVENTORSHIP (FORM 5) [30-08-2023(online)].pdf 2023-08-30
6 202317058209-COMPLETE SPECIFICATION [30-08-2023(online)].pdf 2023-08-30
7 202317058209-Proof of Right [17-10-2023(online)].pdf 2023-10-17
8 202317058209-FORM-26 [19-10-2023(online)].pdf 2023-10-19
9 202317058209-FORM 3 [27-02-2024(online)].pdf 2024-02-27
10 202317058209-FORM 18 [06-02-2025(online)].pdf 2025-02-06